Stock Information
Johnson & Johnson (JNJ)
Ticker Symbol: JNJ
Exchange: NYSE
Sector: Pharmaceuticals
Market Cap: $585,555.08 mil
Piotroski score: 4
PE Ratio: 25.3307
EPS (TTM): 8.6452
Revenue (TTM): $39.41 M
Dividend Yield: 2.4088804997528%
ROE: 33.78%
Latest News
-
Nationwide Survey: 83% of Americans Are Worried Social Security Won’t Survive, and Here’s What to Do About It
Fri, May 8, 2026 4:41 PM
-
3 Unstoppable Dividend King Stocks to Buy Right Now for Less Than $550
Fri, May 8, 2026 12:20 PM
-
Warren Buffett and Berkshire Hathaway Own 2 Dividend Kings That Will Never Be Sold
Fri, May 8, 2026 11:50 AM
-
DARZALEX royalties drive Genmab’s Q1 revenue higher amid expansion push
Thu, May 7, 2026 6:46 PM
-
Johnson And Johnson Balances Mental Health Push With Mixed Pipeline Outlook
Thu, May 7, 2026 5:13 PM
-
Darzalex, Erleada & New Drugs Keep J&J's Oncology Engine Charged in Q1
Thu, May 7, 2026 3:42 PM
-
Why This Income Pro Likes Banks, Chip-Equipment Companies, and More
Thu, May 7, 2026 3:34 PM
-
Johnson & Johnson launches "Generation Fine," a New Movement Encouraging Patients to Expect More from Depression Treatment and Aim for Remission
Thu, May 7, 2026 12:00 PM
-
Lilly, Gilead lead pharma’s M&A boom
Thu, May 7, 2026 8:52 AM
-
Breach Of Contract, IP Rights, And Irreparable Harm: Lessons From The Third Circuit’s Stelara Decision
Thu, May 7, 2026 6:09 AM
Key Financials
Financial data not available
